Trademark Details For KBI BIOPHARMA (Serial Number 88282125)

  •  Home
  •  Print
KBI BIOPHARMA
0
0
0
0
Basic Information
Serial Number  United States - USPTO 88282125
Registration Number 5839075
Mark
KBI BIOPHARMA
Filing Date Jan-30-2019
Status
Registered  
SECTION 8 & .. (702)
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Attorney Name
TTAB
0


  • KBI BIOPHARMA, INC.

  • Description Of Mark:
  • Color(s) Claimed:

040Material treatment

U.S Class(es): 100, 103, 106

Class Status: Active

First Use: May-01-2012

First Use in Commerce: May-01-2012

042Computer, scientific and legal

U.S Class(es): 100, 101

Class Status: Active

First Use: May-01-2012

First Use in Commerce: May-01-2012


26.01.21
26.01.31
26.17.01
26.17.06



Correspondences

NameF. Michael Sajovec Williams Mullen, c/o IP Docketing
Address200 South 10th Street, Suite 1600 Williams Mullen Center Richmond, VA 23219 United States

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Feb-02-2019NEW APPLICATION ENTERED   NWAPI
Feb-22-2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Mar-21-2019NOTICE OF DESIGN SEARCH CODE E-MAILED   MDSCE
Apr-11-2019ASSIGNED TO EXAMINER   DOCKD
Apr-16-2019EXAMINERS AMENDMENT -WRITTEN   CNEAR
Apr-16-2019EXAMINERS AMENDMENT E-MAILED   GNEAF
Apr-16-2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED   GNENO
Apr-16-2019EXAMINER'S AMENDMENT ENTERED   XAECI
Apr-16-2019APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Apr-29-2019ASSIGNED TO LIE   ALIEA
Apr-30-2019LAW OFFICE PUBLICATION REVIEW COMPLETED   PREVO
May-15-2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Jun-04-2019PUBLISHED FOR OPPOSITION   PUBOA
Jun-04-2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Aug-20-2019REGISTERED-PRINCIPAL REGISTER   R.PRA
Aug-20-2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Aug-21-2024TEAS SECTION 8 & 15 RECEIVED   E815I
Jan-15-2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Jan-15-2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Jan-15-2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED   NA85E